Role of chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI ) rechallenge in small cell transformation after EGFR-TKI failure: a case report
Sanghun Lee,1 Jeonghyun Joo,2 Minah Kwak,3 Kicheul Sohn,4 Songha Chon5 1Department of Medical Consilience, Graduate School, Dankook University, Yongin, Republic of Korea; 2Department of Korean Internal Medicine, Comprehensive and Integrative Medicine Hospital, Daegu, Republic of Korea; 3Department...
Main Authors: | Lee S, Joo JH, Kwak MA, Sohn K, Chon SH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/role-of-chemotherapy--with-epidermal-growth-factor-receptor-tyrosine-k-peer-reviewed-article-OTT |
Similar Items
-
Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKI
by: Guo-Hao Xia, et al.
Published: (2014-12-01) -
Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy
in Advanced NSCLC Patients with EGFR Mutations
by: Minjiang CHEN, et al.
Published: (2019-02-01) -
EGFR-TKI-based vs non-EGFR-TKI-based adjuvant therapy in resected non-small-cell lung cancer with EGFR mutations: a meta-analysis of randomized controlled trials
by: Wu JX, et al.
Published: (2018-10-01) -
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations
by: Yutaka Yamada, et al.
Published: (2021-09-01) -
Advances in the Research of Autophagy in EGFR-TKI Treatment and Resistance
in Lung Cancer
by: Qicheng ZHANG, et al.
Published: (2016-09-01)